Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
23%
OVERLAP
BY WEIGHT
28
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
58%
ALSO IN XBI
XBI
137
HOLDINGS
21%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
| AMGEN INC | 3.8% | 1.5% | 1.5% | |
| GILEAD SCIENCES INC | 3.8% | 1.5% | 1.5% | |
| VERTEX PHARMACEUTICALS INC | 3.6% | 1.3% | 1.3% | |
| BIOGEN IDEC INC | 4.1% | 1.3% | 1.3% | |
| REGENERON PHARMACEUTICALS | 3.8% | 1.3% | 1.3% | |
FTXH Overweight Relative to XBI
| MERCK & CO. INC. | 8.4% | |
| JOHNSON & JOHNSON | 8.0% | |
| BRISTOL-MYERS SQUIBB CO | 7.5% | |
| PFIZER INC | 6.4% | |
| ABBVIE INC | 5.0% | |
| CARDINAL HEALTH INC | 4.4% | |
| ELI LILLY & CO | 4.1% | |
| VIATRIS, INC. | 4.0% | |
| BIOGEN IDEC INC | 2.8% | |
| REGENERON PHARMACEUTICALS | 2.5% |
FTXH Underweight Relative to XBI
| MODERNA, INC. | -2.2% | |
| ROIVANT SCIENCES LTD. | -1.7% | |
| VAXCYTE, INC. | -1.7% | |
| ARCELLX, INC. | -1.6% | |
| REVOLUTION MEDICINES, INC. | -1.6% | |
| AMICUS THERAPEUTICS INC | -1.5% | |
| CELCUITY INC. | -1.3% | |
| CG ONCOLOGY, INC. | -1.3% | |
| CRISPR THERAPEUTICS AG | -1.3% | |
| CYTOKINETICS INC | -1.2% |